期刊文献+

HLA-A~*0201/WT1五聚体联合胞内IFNγ染色在检测白血病患者外周血WT1特异性T细胞中的应用

Application of HLA-A~*0201/WT1 Pentamer Combined with Intracellular IFNγ^+ Staining in Detecting Circulating WT1 Specific T Cells in Leukemia
下载PDF
导出
摘要 本研究探讨五聚体及胞内因子染色在定性定量检测抗原特异性T细胞中的应用价值。用RT-PCR方法检测受试者WT1表达水平;用HLA-A*0201/WT1五聚体及胞内IFNγ染色检测14例表达HLA-A*0201的白血病患者全相合移植前后及其供者外周血中的WT1特异性T细胞。结果表明:14例供者中2例有低水平WT1表达,白血病患者均有不同水平的WT1表达。14例供者均未检测到WT1+CD8+CTL和WT1+IFNγ+细胞;移植前14例患者中2例可检出WT1+CD8+CTL,3例检出WT1+IFNγ+细胞,二者间无明显差异(p=0.357),而移植后均可检出WT1+CD8+CTL和WT1+IFNγ+细胞,明显高于移植前(p值均<0.01)。移植后大部分患者均在30天内检出WT1+CD8+CTL和WT1+IFNγ+细胞,但后者检出率高于前者(p=0.014)。14例患者中WT1+CD8+CTL峰值中位数为0.18%,而WT1+IFNγ+细胞峰值中位数为0.83%,明显高于前者(p=0.005);WT1+CD8+CTL峰值中位时间为移植后75天,WT1+IFNγ+细胞峰值中位时间为移植后105天,但二者间无明显差异(p=0.455)。结论:五聚体及胞内IFNγ染色能有效检测白血病患者外周血中白血病抗原特异性T细胞;两种方法联合检测有助于抗原特异性T细胞的准确定性定量检测。 This study was purposed to investigate the value of combination of pentamer and intracellular IFNγ staining in the qualitative and quantitative detection of circulating antigen-specific T cells. WT1 expressions in 14 HLA- A*0201 + patients and their matched donors were detected by RT-PCR, and circulating WT1 specific T cells were assayed by HLA-A* 0201/WT1 pentamer combined with intracellular IFNγ + staining. The results showed that the low level of WTI expression was found only in 2 cases out of 14 donors, but different levels of WT1 expression could be observed in all leukemic patients. The WT1 + CD8 + CTL and WT1 + IFNγ+ cells did not detected in all 14 donors, but WT1 + CD8 + CTL cells in 2 patients and WT1+ IFNγ+ cells in 3 patients could be detected before transplantation respectivelly, there was no significant difference between them, while the WT1+ CD8 + CTL cells and WT1+ IFNγ + cells both could be detected in all 14 patients after transplantation, the positive detection rate after transplantation was obviously higher than that before transplantation. The WT1+ CD8 + and WT1+ IFNγ+ cells could be detected within 30 days after transplantation, but the positive detection rate of WT1 + IFNγ cells was higher than that of WT1+ CD8 + CTL cells (p =0.014). The median peak value of WT1 + CD8 + CTL cells was 0.18% in 14 patients, and the median peak value of WT1 + IFNγ cells was 0.83% in 14 patients, the later was significantly higher than former. The median peak time of WT1+ CD8+ CTL cells was 75 days after transplatation, while the WT1+ IFNγ+ cells was 105 days after transplatation, there was no significant difference beween them. It is concluded that pentamer and intracellular IFNγ staining may effectively detect circulating WT1 specific T cells in leukemic patients, and the combination of these two methods profit to the exact qualitation and quantitation of circulating antigen-specific T cells.
出处 《中国实验血液学杂志》 CAS CSCD 2010年第2期505-509,共5页 Journal of Experimental Hematology
关键词 白血病 HLA—A*020/WTl五聚体 胞内IFNγ染色 WT1特异性T细胞 leukemia HLA-A*0201 pentamer intracellular IFNγ staining WT1 specific T cell
  • 相关文献

参考文献10

  • 1Halverson DC, Schwartz GN, Carter C, et al. In vitro generation of allospecific human CD8^+ T cells of Tcl and To2 phenotype. Blood, 1997;90(5) :2089 -2096.
  • 2孙万军,徐东刚,胡海兰,邹民吉,杜建芳,王金凤,蔡欣,王嘉玺,艾辉胜.可溶性HLA-A*0201-PR1复合物的构建与鉴定[J].中国实验血液学杂志,2007,15(2):352-356. 被引量:1
  • 3Rezvani K, Yong AS, Savani BN, et al. Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia. Blood, 2007; 110(6) :1924 -1932.
  • 4Hui-Sheng Ai, Chun-Hua Zhao, Mei Guo, et al. Mixed hematopoietic chimerism-a new strategy for preventing GVHD in nonmyeloablative allogeneic stem cell transplantation. Experimental Hematology, 2002 ;30 (5) : 119.
  • 5Asemissen AM, Keilholz U, Tenzer S, et al. Identification of a highly immunogenic HLA-A^* 01-Binding T cell epitope of WT1. Clin Cancer Res, 2006 ; 12 (24) : 7476 - 7482.
  • 6Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneicmarrow grafts. N Engl J Med ,1979 ; 300(19) : 1068 - 1073.
  • 7Schulenburg A, Fischer M, Kalhs P, et al. Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation. Leuk Lymphoma, 2005 ; 46 ( 12 ) : 1755 - 1760.
  • 8Tobery TW, Dubey SA, Anderson K, et al. A comparison of standard immunogenicity assays for monitoring HIV type 1 gagspecific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjects. AIDS Res Hum Relax)viruses, 2006 ;22 ( 11 ) : 1081 - 1090.
  • 9Molldrem 22, Lee PP, Wang C, et al. A PR1-Human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia. Cancer Res, 1999 ; 59 ( 11 ) :2675 - 2681.
  • 10Baker J, Vemeris MR, Ito M, et al. Expansion of cytolytic CD8 ( + ) natural killer T cells with limited capacity for graft-versushost disease induction due to interferon gamma production. Blood, 2001 ; 97(10) :2923 -2931.

二级参考文献13

  • 1孙万军,徐东刚,杜建芳,邹民吉,王金凤,蔡欣,王嘉玺,艾辉胜.人β_2-微球蛋白基因的克隆与原核中的表达[J].中国实验血液学杂志,2006,14(3):521-524. 被引量:1
  • 2孙万军,杜建芳,徐东刚,邹民吉,王金凤,蔡欣,王颖,王嘉玺,艾辉胜.HLA-A*0201-BSP融合基因的构建与原核表达[J].中国实验血液学杂志,2006,14(5):976-980. 被引量:1
  • 3Altman JD,Moss PA,Goulder PJ,et al.Phenotypic analysis of antigen-specific T lymphocytes.Science,1996; 274 (5284):94-96
  • 4Barnes E,Ward SM,Kasprowicz VO,et al.Ultrasensitive class Ⅰ tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells.Eur J Immunol,2004; 34:1570-1577
  • 5Palmowski M,Salio M,Dunbar RP,et al.The use of HLA class Ⅰ tetramers to design a vaccination strategy for melanoma patients.Immunol Rev,2002; 188:155-163
  • 6Yuan RR,Wong P,McDevitt MR,et al.Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers.Blood,2004;104:2397-2402
  • 7Garboczi DN,Hung DT,Wiley DC,et al.HLA-A2-peptide complexes:refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigen peptide.Proc Natl Acad Sci USA,1992; 89:3429-3433
  • 8Dengler R,Munstermann U,al-Batran S,et al.Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells.Br J Haematol,1995; 89:250-257
  • 9Molldrem JJ,Clave E,Jiang YZ,et al.Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units.Blood,1997;90:2529-2534
  • 10Parker KC,Silver ML,Wiley DC.An HLA-A2/β2m/peptide complex assembled from subunits expressed separately in Escherichia coli.Mol Immunol,1992; 29:371 -378

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部